v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 23,890,811 $ 7,908,181
Accounts receivable 354,083 216,504
Receivable from noncontrolling interests 0 721,548
Prepaid expenses and other current assets 1,931,708 1,664,023
Total current assets 26,176,602 10,510,256
Property and equipment, net 14,362,828 10,712,839
Operating lease right-of-use assets, net 1,480,266 1,258,701
Goodwill 3,165,531 3,267,103
Other noncurrent assets 200,217 1,793,014
Total assets 45,385,444 27,541,913
Current liabilities:    
Accounts payable 2,222,658 1,111,819
Accrued expenses 1,768,767 1,311,245
Notes payable 206,570 470,396
Finance lease liabilities - current 60,835 61,941
Operating lease liabilities - current 504,425 336,564
Deferred revenue 882,000 882,000
Other current liabilities 1,274,091 1,500,000
Share liability 413,000 0
Total current liabilities 7,332,346 5,673,965
Deferred tax liabilities 57,398 110,578
Convertible notes payable, at fair value 22,017,458 0
Finance lease liabilities - noncurrent 185,407 207,092
Operating lease liabilities - noncurrent 1,112,817 1,066,647
Other liabilities 1,653,000 1,653,000
Total liabilities 32,358,426 8,711,282
Stockholders' equity    
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2024 and December 31, 2023 0 0
Common stock, $0.01 par value; 500,000,000 shares authorized, 48,598,276 and 48,923,276 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 485,983 489,233
Additional paid-in capital 42,283,907 40,567,003
Accumulated deficit (30,787,385) (23,839,300)
Accumulated other comprehensive loss (1,464,711) (920,982)
Total ASP Isotopes stockholders' equity 10,517,794 16,295,954
Noncontrolling interests 2,509,224 2,534,677
Total stockholders' equity 13,027,018 18,830,631
Total liabilities and stockholders' equity $ 45,385,444 $ 27,541,913

Source

HTML PDF
ZIP